Allworth Financial’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
Allworth Financial's INMB Position: Q3 2026 in Review
Allworth Financial reduced its INmune Bio (INMB) stake by 90% in Q3 2026, selling an estimated $2.3K and leaving 125 shares worth $244. The position accounts for ﹤0.01% of the portfolio, ranked #5194.
Allworth Financial first reported a position in INMB in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.02K in Q2 2026. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.
- Allworth Financial held 125 shares of INmune Bio worth $244 as of Q3 2026.
- Allworth Financial sold 1,116 INmune Bio shares in Q3 2026, an estimated $2.3K.
- INmune Bio made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #5194 holding.
- Allworth Financial first reported a position in INmune Bio in Q1 2026 and has held it in 3 quarters since.
- Allworth Financial's INmune Bio position peaked at $2.02K in Q2 2026.
- 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.
Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.